Abiopharma

🔍 Berg Aaron (Executive)

Company: AMARIN CORP PLC\UK (AMRN)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 6,250 shares of American Depositary Shares (Direct)
  Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 88,845.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F3, F1
• Sold 3,197 shares of American Depositary Shares at $16.35 per share (Direct)
  Date: 2026-06-26 | Code: F | equity_swap_involved: false | shares_owned_after: 85,648.00 | transaction_form_type: 4 | Footnotes: F1, F4, F1, F1
• Acquired 6,250 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 6,250.00 | transaction_form_type: 4 | Footnotes: F5, F1, F2, F3, F1, F1, F1

Footnotes:

• F1: Effective April 11, 2025, the Issuer implemented a ratio change that one (1) American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares ("ADS Ratio Change"). Proportionate adjustments were made to the Issuer's outstanding equity awards. The amount of securities reported on this Form 4 reflect the ADS Ratio Change.
• F2: On June 26, 2025, the Reporting Person was granted 12,500 RSUs that vests in two equal installments on the first anniversary of the grant date and the remaining balance to vest eighteen months after grant date.
• F3: Not applicable.
• F4: Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
• F5: Each RSU represents a contingent right to receive twenty Ordinary Shares or cash in lieu thereof at the Issuer's discretion.